Artériopathie oblitérante des membres inférieurs (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Artériopathie oblitérante des membres inférieurs" in French language version.

refsWebsite

Global rank French rank

3ama-assn.org

3,257^th place

1,028^th place

2sciencedirect.com

149^th place

80^th place

2ahajournals.org

3,608^th place

659^th place

2has-sante.fr

9,562^nd place

535^th place

2bmj.com

1,226^th place

347^th place

2wiley.com

222^nd place

129^th place

1oup.com

485^th place

416^th place

1nejm.org

2,374^th place

298^th place

1nih.gov

4^th place

12^th place

1oxfordjournals.org

1,389^th place

508^th place

1sagepub.com

731^st place

771^st place

1annals.org

low place

1,894^th place

ahajournals.org

circ.ahajournals.org

(en) Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. « ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) » Circulation 2006;113:e463-654.
Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, Wilson PWF, Association of statin dose with amputation and survival in patients with peripheral artery disease, Circulation, 2018;137:1435–1446

ama-assn.org

jama.ama-assn.org

(en) McDermott MM, Ades P, Guralnik JM et al. « Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial » JAMA 2009;301:165–74.
(en) Berger JS, Krantz MJ, Kittelson JM et al. « Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials » JAMA 2009;301:1909–19.
(en) Fowkes FG, Murray GD, Butcher I et al. « Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis » JAMA 2008;300:197–208.

annals.org

(en) Selvin E, Marinopoulos S, Berkenblit G et al. « Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus » Ann Intern Med. 2004;141:421-31.

bmj.com

(en) De Backer T, Vander Stichele R, Lehert P, Van Bortel L. « Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data » BMJ 2009;338:b603.
(en) Peach G, Griffin M, Jones KG, Thompson MM, Hinchliffe RJ. « Diagnosis and management of peripheral arterial disease » BMJ 2012;345:e5208.

has-sante.fr

Artériopathie chronique oblitérante des membres inférieurs (AOMI) 3^e vague de réévaluation des médicaments - 2006.
« Le service médical rendu de ces spécialités reste faible dans le traitement symptomatique de la claudication intermittente des artériopathies chroniques oblitérantes des membres inférieurs (stade II) pour l'ensemble de la population concernée par cette indication, quelles que soient les modalités de prise en charge par l'assurance maladie » • Avis de la commission de transparence de la HAS française du 7 avril 2010.

nejm.org

(en) Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. « Exercise training for claudication » N Engl J Med. 2002;347:1941–51.

nih.gov

ncbi.nlm.nih.gov

(en) Bradbury AW, Adam DJ, Bell J et al. « Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy » J Vasc Surg. 2010;51:5S–17S. PMID 20435258.

oup.com

academic.oup.com

Mazzolai L, Teixido-Tura G, Lanzi S et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM), European Heart Journal, 2024;45:3538–3700

oxfordjournals.org

ije.oxfordjournals.org

(en) Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ, « Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population » Int J Epidemiol. 1991;20:384-92.

sagepub.com

vmj.sagepub.com

(en) MH Criqui. « Peripheral arterial disease—epidemiological aspects » Vasc Med. 2001;6(Suppl 1):3–7.

sciencedirect.com

(en) Moneta GL, Yeager RA, Antonovic R et al. « Accuracy of lower extremity arterial duplex mapping » J Vasc Surg. 1992;15:275-83.
(en) Gerhard-Herman MD, Gornik HL, Barrett C, 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, J Am Coll Cardiol, 2017;69:e71-e126

wiley.com

onlinelibrary.wiley.com

(en) Quick CR, Cotton LT. « The measured effect of stopping smoking on intermittent claudication » Br J Surg. 1982;69 Suppl:S24–S26.

mrw.interscience.wiley.com

(en) Robless P, Mikhailidis DP, Stansby GP. « Cilostazol for peripheral arterial disease » Cochrane Database Syst Rev. 2008;(1):CD003748.